List of companies in Takeda Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
BiomX is a biotechnology company developing phage therapies for eradicating bacteria associated with chronic diseases. | ||||||
Develops novel cell and gene therapies with pharmacologic operating systems. | ||||||
Cortexyme is a biotechnology company with a focus on developing therapeutics for Alzheimer's disease and other neurodegenerative diseases. It was founded in 2012 and is located in San Francisco, California. | ||||||
Univercells is a Belgium-based bio manufacturing company founded in 2013. | ||||||
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases. | ||||||
Avidity Biosciences is a biotechnology company developing RNA-based therapeutics that is headquartered in San Diego, California. | ||||||
Ultragenyx Pharmaceutical is a Novato, California-based company. | ||||||
Developer of p300/CBP small-molecule inhibitor drug to treat cancer. | ||||||
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing treatments for patients with gastrointestinal disorders. | ||||||
Emendo Biotherapeutics is a New York City-based biotechnology and synthetic biology company. | ||||||
Xilio Therapeutics is a cancer Immunotherapies founded in 2016 by Rene Russo. | ||||||
StrideBio is a Durham, North Carolina-based company. | ||||||
Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity. | ||||||
Gene writing tools provider to improve the safety, precision, and efficacy of advanced therapies. | ||||||
A biotechnology company developing immuno-oncology therapies and therapeutic vaccines | ||||||
Koneksa Health is a New York City-based company founded in 2015. | ||||||
Biotherapies developer targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases. | ||||||
Palleon Pharmaceuticals is a glycoimmune Checkpoint Inhibitors founded in 2016. | ||||||
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015. | ||||||
Ensoma, Inc. is an in vivo Gene Therapy founded in 2019. | ||||||
Platform for increasing protein production in the body using specialized translation enhancers. | ||||||
A company focused on developing therapeutics for the treatment of depression and other central nervous system disorders | ||||||
Catamaran uses NK cells, synthetic biology, and non-viral cell engineering to create novel CAR-NK cell therapies. | ||||||
ImmPACT Bio is a company founded in 2019. | ||||||
ArmaGen Technologies is a Calabasas, California-based company founded by William M. Pardridge. |
